Navigation Links
PCI's Response to Swine Flu Evolves to Keep Pace with Emerging Health Threat
Date:4/28/2009

SAN DIEGO, April 28 /PRNewswire-USNewswire/ -- PCI continues to closely monitor the swine flu outbreak both in Mexico where we have major programming and staff, as well as in San Diego. Since Thursday, PCI staff in San Diego, Washington, DC and throughout Mexico, have diligently kept pace with this growing health issue, as we determine our organizational priorities and focus our attention and resources where they could do the most good for the greatest number of people.

"PCI is working to address the current outbreak of the swine flu. Our goal is to assist in ensuring people have access to the information and health service support they need to immediately combat and overcome this growing health issue," said President and CEO, George Guimaraes.

PCI is currently implementing a 3-pronged approach to fighting the epidemic in Mexico and the United States. In partnership with Americares and several donors, PCI is working to ensure that much needed medical and disease mitigation supplies are provided quickly to those most in need and most at risk. Building upon community contacts and partners in the media throughout Mexico, PCI is ensuring that practical, easy to follow guidance on prevention, diagnosis and treatment will be made available to vulnerable people. PCI is supporting and mobilizing its staff and partners in more than 13 Mexican states, and in San Diego County, to ensure that the health care systems, infrastructure and capacity that already exist can be readily adapted and utilized to manage the situation effectively.

If we are facing a pandemic, the fall out in terms of economies, food security, and vulnerability in general will require robust multi-pronged integrated programming--it won't just be the flu we are dealing with, but its associated impacts in already vulnerable communities.

PCI staff in San Diego, Washington DC, and throughout Mexico have diligently kept pace with this fast growing public health issue, as we determine our organizational priorities and focus our attention and resources where they could do the most good. At PCI, we continue to strengthen how we work across communities and countries to reinforce those strategies that are yielding positive results, and address our underlying vulnerabilities.

For more information about Project Concern International, go to our website at www.ProjectConcern.org.

SAVING LIVES AND BUILDING HEALTHY COMMUNITIES

Project Concern International (www.ProjectConcern.org) is a San Diego-based health and humanitarian organization dedicated to building healthy communities by preventing disease, improving community health, and promoting sustainable development. With over 47 years of experience, Project Concern International reached more than 4.5 million people in 2008 through life-saving programs in Asia, Africa, and the Americas.


'/>"/>
SOURCE Project Concern International (PCI)
Copyright©2009 PR Newswire.
All rights reserved

Related medicine news :

1. Tumors use enzyme to recruit regulatory T-cells and suppress immune response
2. Study identifies key player in the bodys immune response to chronic stress
3. Retired NYPD Lieutenants William E. Keegan, Jr., Owen McCaffery and John Moran and Tom Thees, a former COO in the financial industry, announce today the formation of H.E.A.R.T (Healing Emergency Aid Response Team) 911.
4. Response Biomedical appoints S. Wayne Kay Chief Executive Officer
5. Merck & Co., Inc. Response to Todays New York Medicaid Suit
6. Maternal depression and controlling behavior associated with increased stress response in infants
7. Family history of alcoholism affects response to drug used to treat heavy drinking
8. Molecular fingerprint of breast-cancer drug resistance can predict response to treatment
9. Breast cancer susceptibility gene predicts outcome and response to treatment in lung cancer
10. PET scans can accurately detect a breast tumors response to chemotherapy
11. DNA damage response confers a barrier for viral tumorigenesis
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/20/2017)... ... September 20, 2017 , ... Demand generation pioneer ... East-coast edition of MarTech: The Marketing Tech Conference October 2–4, at the Hynes ... 40 speakers — representing such thought-leading companies as JP Morgan Chase, GE ...
(Date:9/20/2017)... ... September 20, 2017 , ... Compliancy ... industry-leading compliance software, The Guard®, has helped another long-time client pass their Department ... and properly satisfy the law. , Thanks to the help of the Compliancy ...
(Date:9/20/2017)... ... September 20, 2017 , ... ... campaign, “Humans With Vaginas.” The goal is to ignite conversation via social media ... care products. The brand has declared September “Humans with Vaginas” month, releasing a ...
(Date:9/20/2017)... (PRWEB) , ... September 20, 2017 , ... ... millions of older Americans at risk of price gouging for their prescription drugs, ... League (TSCL) . “Because Medicare isn’t negotiating on our behalf, there’s no consistency ...
(Date:9/20/2017)... ... ... “The Trials I Face to Receive God’s Grace”: a mesmerizing take on one ... better one’s life through God. “The Trials I Face to Receive God’s Grace” is ... found a love for writing. Green feels that expressing his feelings through prayer will ...
Breaking Medicine News(10 mins):
(Date:9/7/2017)... 2017   BioLife Solutions , Inc. (NASDAQ: ... clinical grade cell and tissue hypothermic storage and ... Rice , President and CEO, will be presenting at two ... & Renshaw 19 th Annual Global Investment Conference on ... Pacific time). The conference is being held at the New ...
(Date:9/6/2017)... , Sept. 6, 2017  Medical professionals ... and skills while treating their patients. Medical ... experience without involving patients. Simulation provides a ... can carry out procedures, refine techniques and ... Integration of new technology, such as augmented ...
(Date:9/6/2017)... -- NeuroRx, a clinical stage biopharma company developing the first ... been granted Fast Track status by the US Food and ... followed by NRX-101 (D-cycloserine + lurasidone). The company will shortly ... therapy targeting patients who are admitted to Emergency Departments with ... ...
Breaking Medicine Technology: